Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gene Mutation-Related Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00186212
What this trial is testing

Alternative Support for Rural and Isolated Women in an HMO

Who this might be right for
Stress Disorders, Post-traumaticDepressionBreast Cancer
Stanford University 150
Not applicableLooking for participantsNCT06089421
What this trial is testing

Genetic Information Assistant in Telegenetics

Who this might be right for
Gene Mutation-Related CancerGenetic Predisposition
University of Virginia 96
Not applicableEnrolling By InvitationNCT06807515
What this trial is testing

Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission

Who this might be right for
CancerCancer Survivor
Thong Chai Institute of Medical Research 24
Very early researchEnded earlyNCT03272633
What this trial is testing

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation Recipient+16 more
Rutgers, The State University of New Jersey 2
Early research (Phase 1)Looking for participantsNCT05661201
What this trial is testing

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Who this might be right for
Solid TumorKRAS Mutation-Related Tumors
Georgetown University 24
Testing effectiveness (Phase 2)Looking for participantsNCT05786924
What this trial is testing

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Who this might be right for
Non-small Cell Lung CancerHistiocytic NeoplasmHistiocytosis+29 more
Institut de Recherches Internationales Servier 554
Testing effectiveness (Phase 2)Study completedNCT01253070
What this trial is testing

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1+3 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT02553642
What this trial is testing

Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

Who this might be right for
Bladder CancerMelanoma
Memorial Sloan Kettering Cancer Center 81
Not applicableLooking for participantsNCT01689584
What this trial is testing

COsegregation of VARiants in Panel of Genes

Who this might be right for
Gene Mutation-Related CancerGenetic Predisposition
Institut Curie 11,000
Testing effectiveness (Phase 2)UnknownNCT05847764
What this trial is testing

Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations

Who this might be right for
Non Small Cell Lung CancerERBB2 Mutation-Related TumorsRC48+1 more
Sun Yat-sen University 95
Early research (Phase 1)Looking for participantsNCT06902376
What this trial is testing

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerBRAF Mutation-Related Tumors
UNC Lineberger Comprehensive Cancer Center 12
Not applicableStudy completedNCT03424213
What this trial is testing

Race-related Alternative Splicing: Novel Targets in Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 169
Large-scale testing (Phase 3)Study completedNCT03551626
What this trial is testing

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

Who this might be right for
Malignant Melanoma
Novartis Pharmaceuticals 552
Testing effectiveness (Phase 2)Ended earlyNCT02822482
What this trial is testing

Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
UNICANCER 11
Not applicableStudy completedNCT04481152
What this trial is testing

Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma

Who this might be right for
Genetic PredispositionSDH Gene MutationEnvironmental Exposure
Assistance Publique - Hôpitaux de Paris 101
Early research (Phase 1)Ended earlyNCT06685718
What this trial is testing

A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung CancerNSCLC+3 more
BeOne Medicines 33
Not applicableStudy completedNCT07187986
What this trial is testing

Sound Acupuncture in Painful Chemotherapy-Related Neuropathies

Who this might be right for
Neuropathic Pain in Cancer
Ente Ospedaliero Ospedali Galliera 40
Not applicableUnknownNCT00897455
What this trial is testing

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
Gynecologic Oncology Group 10,000
Not applicableUnknownNCT05136014
What this trial is testing

Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model

Who this might be right for
Lung CancerLung AdenocarcinomaEGFR Activating Mutation+2 more
Central Hospital, Nancy, France 200
Testing effectiveness (Phase 2)Looking for participantsNCT05983159
What this trial is testing

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

Who this might be right for
Slow-Flow Vascular MalformationFast-Flow Vascular MalformationVascular Malformations+15 more
Murdoch Childrens Research Institute 50
Next Page